NCT02513524View on ClinicalTrials.gov

Prevalence of Resistant Hypertension With DOT

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

September 30, 2018

Conditions
Hypertension
Interventions
PROCEDURE

Direct Observed Therapy test

There is one group only, all of whom will undergo direct observed therapy testing

Trial Locations (1)

K1H7W9

Ottawa Hospital Research Institute, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER